ARLZ

Aralez Pharmaceuticals Inc.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aralez Pharmaceuticals Inc. market cap is $1.73M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Aralez Pharmaceuticals Inc. 52 week high is $2.98 as of October 28, 2025.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aralez Pharmaceuticals Inc. 52 week low is $0.013 as of October 28, 2025.

Aralez Pharmaceuticals Inc. stock price today is $0.0255.

Aralez Pharmaceuticals Inc. stock price yesterday was $0.0257.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Aralez Pharmaceuticals Inc.’s P/E ratio is None.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Aralez Pharmaceuticals Inc. P/B ratio is -0.2625.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Aralez Pharmaceuticals Inc.'s EBITDA is -20.46.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aralez Pharmaceuticals Inc. 50-day moving average is $0.1806.

Aralez Pharmaceuticals Inc. has 164 employees.